Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 5)

v3.7.0.1
Stockholders' Equity (Details 5)
9 Months Ended
Mar. 31, 2017
$ / shares
shares
Number of Options  
Number of options unvested, Beginning balance | shares 141,016
Number of unvested options, Granted | shares 264,600
Number of options, Vested | shares (59,411)
Number of options unvested, Ending balance | shares 346,205
Weighted average exercise price  
Weighted average exercise price unvested, Beginning balance $ 3.17
Weighted average exercise price unvested, Granted 4.82
Weighted average exercise price unvested, Vested 4.14
Weighted average exercise price unvested, Ending balance 4.59
Weighted average grant date fair value  
Weighted average grant date fair value, unvested, Beginning balance 1.73
Weighted average grant date fair value, unvested, Granted 2.61
Weighted average grant date fair value, unvested, Vested 2.26
Weighted average grant date fair value, unvested, Ending balance $ 2.49